Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia? Read more about Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma. Read more about Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma.
Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes. Read more about Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes.
IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma. Read more about IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma.
Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma. Read more about Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Read more about Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean.
A mechanism for Ikaros regulation of human globin gene switching. Read more about A mechanism for Ikaros regulation of human globin gene switching.
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. Read more about Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Read more about Clinical differences between children and adults with pulmonary hypertension and sickle cell disease.
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Read more about Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
